An Open-label, Single-sequence Study to Assess the Effect of Multiple Doses of Tradipitant on Cytochrome P450 3A4 Using Midazolam as a Substrate in Healthy Subjects.

Trial Profile

An Open-label, Single-sequence Study to Assess the Effect of Multiple Doses of Tradipitant on Cytochrome P450 3A4 Using Midazolam as a Substrate in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Apr 2016

At a glance

  • Drugs Tradipitant (Primary) ; Midazolam
  • Indications Pruritus
  • Focus Pharmacokinetics
  • Sponsors Vanda Pharmaceuticals
  • Most Recent Events

    • 26 Apr 2016 Status changed from recruiting to completed.
    • 08 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top